What's new

Filters: policy
x
Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Medicines For Europe Country Specific Market Access Policies

24 May 2018

Policy

Open

Positioning Statements on Physician-led Switching for Biosimilar Medicines

27 April 2018

Policy

Positioning Statements on Physician-led Switching for Biosimilar Medicines BIOSIMILAR MEDICINES […]

Read more

IGBA position on identification of biological, including biosimilar medicines (2018 update of facts & figures)

20 April 2018

Policy

Open

Life Science Industry Coalition Position paper

14 December 2017

Policy

Open

Position Paper: for an ambitious EU industrial strategy

24 October 2017

Policy

Open

SPC manufacturing waiver

24 October 2017

Policy

SME Intergroup Conclusions – Boosting SMEs through the SPC Waiver […]

Read more

Fighting counterfeit medicines in Europe: the effect on access to medicines

14 September 2017

Policy

The implementation of the Falsified Medicines Directive, and its Delegated […]

Read more

US FDA Advisory committee hears first-hand about the decade of EU experience with biosimilar medicines use

13 July 2017

Policy

Medicines for Europe Director General Adrian van de Hoven participated […]

Read more

Medicines for Europe Country Specific Market Access Policies

23 May 2017

Policy

Open

Essential Medicines for Universal Health Coverage

7 November 2016

Policy

Open

Subscribe to our newsletter